Kalaris Therapeutics Inc (KLRS) Investor Relations Documents

Kalaris Therapeutics Inc (KLRS) investor relations documents from the company's IR site: 3 presentations, 12 press releases; latest deck 2026-08-01. Read in-app with summaries. First-party data.

Corporate Presentation - August 2026: Kalaris is a clinical-stage biopharma developing TH103, a next-generation anti-VEGF fusion protein for retinal diseases, with Phase 1b/2 data expected in 1H 2027.

Investor relations documents — source: company IR site
PublishedTypeDocument
2026-08-11Press releaseKalaris Reports Second Quarter 2026 Financial Results and Provides Business Updates
2026-08-01PresentationCorporate Presentation - August 2026
2026-07-20Press releaseKalaris Expands Leadership Team Appointing Liisa Bayko as Chief Financial Officer
2026-07-17PresentationTH103 Ph 1a Data Presentation
2026-07-17Press releaseKalaris Therapeutics Reports Positive TH103 Phase 1a SAD Results from Expanded Neovascular AMD Cohorts
2026-07-06Press releaseKalaris Appoints Laurie Keating to Board of Directors
2026-06-23Press releaseKalaris Announces Upcoming Presentation of TH103 Phase 1a Clinical Data at American Society of Retina Specialists; Ph 1b
2026-06-12Press releaseKalaris to Present at Clinical Trials at the Summit 2026
2026-05-12Press releaseKalaris Reports First Quarter 2026 Financial Results and Provides Business Updates
2026-03-17Press releaseKalaris Reports Full Year 2025 Financial Results and Provides Business Updates
2026-01-28Press releaseKalaris to Present Phase 1 Clinical Data for TH103 at the Macula Society Annual Meeting
2025-12-18PresentationTH103 Phase 1a Data Presentation
2025-12-17Press releaseKalaris Therapeutics Reports Positive Initial Phase 1a Data for TH103 in Treatment-Naïve Neovascular AMD
2025-12-17Press releaseKalaris Therapeutics Announces Oversubscribed $50.0 Million Private Placement
2025-11-03Press releaseKalaris Expands Leadership Team Appointing Matthew Gall, MBA, as Chief Financial Officer

KLRS overview · KLRS earnings · KLRS financials · KLRS KPIs · KLRS ownership · KLRS peers · KLRS filings

Documents published by the company on its investor-relations site; summaries are model-written. Not personalized investment advice.